Cargando…

Expression of Transforming Growth Factor beta-1 in Chronic Hepatitis and Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection

BACKGROUND: Transforming growth factor beta-1 (TGFβ 1) has been suggested to play a role in the development, growth or progression of hepatocellular carcinoma (HCC). Genotype and serum titer of HCV also affect the occurrence of HCC in chronic hepatitis C. In this study, we were to evaluate the effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyung Gun, Chung, Young-Hwa, Song, Byung-Cheol, Kim, Jeong A., Yang, Soo Hyun, Lee, Yung Sang, Suh, Dong Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2000
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531768/ https://www.ncbi.nlm.nih.gov/pubmed/11242803 http://dx.doi.org/10.3904/kjim.2000.15.3.165

Ejemplares similares

Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma
por: Yang, Suh Yoon, et al.
Publicado: (2014)

Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
por: Shin, Seung Kak, et al.
Publicado: (2021)

Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis
por: Kim, Jonghwa, et al.
Publicado: (2020)

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis
Publicado: (1989)

Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization
por: Sung, Pil Soo, et al.
Publicado: (2011)

Influence of Transforming Growth Factor-β1 Gene Polymorphism at Codon 10 on the Development of Cirrhosis in Chronic Hepatitis B Virus Carriers
por: Yu, Sang Kyun, et al.
Publicado: (2010)

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
por: Park, Hye Kyong, et al.
Publicado: (2019)

Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study
por: An, Jihyun, et al.
Publicado: (2018)

Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea
por: Kwon, Jae-Cheol, et al.
Publicado: (2018)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

Xanthoma Striatum Palmare in a Patient of Primary Biliary Cirrhosis with Autoimmune Hepatitis
por: Yang, Min-Young, et al.
Publicado: (2017)

Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
por: Kim, Soo Ryang, et al.
Publicado: (2023)

Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
por: Kwon, Oh Sang, et al.
Publicado: (2010)

A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

Hepatic inflammatory pseudotumor misinterpreted as hepatocellular carcinoma
por: Jeong, Jae Yoon, et al.
Publicado: (2012)

Inhibition of Transforming Growth Factor Beta and Immune Checkpoints Induces a Distinctively Distributed, Severe Bullous Pemphigoid
por: CHOI, Soo Hyun, et al.
Publicado: (2021)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
por: Yang, Chengkun, et al.
Publicado: (2018)

Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway
por: Seo, Hye-Young, et al.
Publicado: (2017)

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
por: Kim, Yu Jin, et al.
Publicado: (2011)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
por: Jang, Jeong Won, et al.
Publicado: (2021)

A Case of Hepatic Angiomyolipoma Which Was Misdiagnosed as Hepatocellular Carcinoma in a Hepatitis B Carrier
por: Hwang, Jin Yeon, et al.
Publicado: (2012)

Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma
por: Chung, Jung Wha, et al.
Publicado: (2017)

Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
por: Kim, Soo Ki, et al.
Publicado: (2022)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
por: Shim, Chang Woo, et al.
Publicado: (2017)

Hepatic metastases from hepatoid adenocarcinoma of stomach mimicking hepatocellular carcinoma
por: Jo, Jae Myeong, et al.
Publicado: (2012)

Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
por: Kim, Cha Young, et al.
Publicado: (2017)

Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
por: Kim, Wan Soo, et al.
Publicado: (2016)

De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody
por: Han, Jae Hyun, et al.
Publicado: (2015)

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
por: Kwan, Byung Soo, et al.
Publicado: (2021)

Increased Transforming Growth Factor-beta1 in Alcohol Dependence
por: Kim, Yong-Ku, et al.
Publicado: (2009)

TRAIL Enhances Apoptosis of Human Hepatocellular Carcinoma Cells Sensitized by Hepatitis C Virus Infection: Therapeutic Implications
por: Jang, Jae Young, et al.
Publicado: (2014)

Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression
por: Lim, Jung Hwa, et al.
Publicado: (2019)

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Prognostic factors after hepatic resection for the single hepatocellular carcinoma larger than 5 cm
por: Noh, Ji Hyun, et al.
Publicado: (2016)

Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model
por: Kim, Jieun, et al.
Publicado: (2023)

Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma
por: Kim, Bu-Yeo, et al.
Publicado: (2015)

Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C
por: Kim, Gun-Wook, et al.
Publicado: (2013)

A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma
por: Lee, Hae Won, et al.
Publicado: (2018)

Hepatic hydrothorax without ascites as the first sign of liver cirrhosis
por: Kim, Jung Soo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2jfqqims8dkpv8afed23tdh26n